GastroHep News Story

Home

News and Views

News

Reference

Advanced Digestive Endoscopy

Education

Classical Cases

Links and Services

Conference Diary

PubMed

International GH Links

USA GH Links

National GH Links

National GI Societies

Cytomegalovirus reactivation influences the course of IBD

A study in the latest issue of the Alimentary Pharmacology & Therapeutics evaluates the impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.

News image

Consequences of latent cytomegalovirus (CMV) infection reactivation on inflammatory bowel disease

Aliment Pharmacol Ther 2014: 39(7): 712–720
17 March 2014

Email this page to a colleague


23 October 2017
NAFLD-related hepatocellular carcinoma in liver resection


23 October 2017
Outcome of hepatic sarcoidosis


23 October 2017
Irradiated rectal cancer and chemoradiotherapy


20 October 2017
Hospital readmissions reduction program


20 October 2017
Conversion of planned colonoscopy to sigmoidoscopy


20 October 2017
Food elimination diets for treatment of adults with eosinophilic esophagitis


19 October 2017
Fecal immunochemical tests in colorectal cancer screening


19 October 2017
Surgical anastomosis at 1-year colorectal cancer surveillance


19 October 2017
Current management of chylous ascites


18 October 2017
Hep E seroprevalence and hemodialysis


18 October 2017
Prebiotic and changes in the human gut microbiota


18 October 2017
Predicting recurrence after curative rectal cancer surgery


17 October 2017
Laparoscopic surgery use in Medicare patients with colon cancer


17 October 2017
Medication nonadherence and health care costs


17 October 2017
Asthma and IBD development


16 October 2017
Colorectal cancer screening and postpolypectomy surveillance colonoscopy


16 October 2017
Continuity of care after colorectal surgery


16 October 2017
Breastfeeding and the risk of IBD


13 October 2017
Treating patients with HCV and severe renal impairment


13 October 2017
Blood pressure management during abdominal surgery


13 October 2017
Food elimination diets for eosinophilic esophagitis


12 October 2017
Global recurrence of H. pylori


12 October 2017
Colonoscopy in an organized colorectal cancer screening program


12 October 2017
Predicting advanced fibrosis in chronic hepatitis B


11 October 2017
Fecal microbiota transplantation for ulcerative colitis


11 October 2017
Sexual functioning in Hep C


11 October 2017
Ulcerative proctitis in pediatric-onset UC


10 October 2017
Quality standards in upper gastrointestinal endoscopy


10 October 2017
Eosinophilic esophagitis and swallowed topical corticosteroids


10 October 2017
Follow-up of positive results on fecal blood tests


09 October 2017
Diverticulitis and emergency department burden


09 October 2017
Global recurrence rate of H. pylori


09 October 2017
Clostridium difficile infection after ileostomy reversal


06 October 2017
Predicting nontreatment for Hep C


06 October 2017
Cow's milk–based formula and development of celiac disease


06 October 2017
Propofol for outpatient colonoscopy


05 October 2017
Pediatric candidates on the transplant wait list


05 October 2017
Incidence of sepsis in the USA


05 October 2017
Quality of life after chemoradiation in rectal cancer


04 October 2017
Peptic ulcer disease diagnosed in acute upper endoscopy


04 October 2017
Clinical practice guidelines in colon cancer


04 October 2017
Rural residence and risk of IBD


03 October 2017
Novel candidate risk genes for IBD


03 October 2017
Antibody tests and detecting celiac disease


03 October 2017
Environmental factors and IBD


02 October 2017
Full publication of Gastroenerology abstracts


02 October 2017
Interferon-free therapy in advanced liver disease


02 October 2017
Burden of NAFLD with advanced fibrosis in the USA


29 September 2017
Inpatient Gastroenterology training experience


29 September 2017
Proteomic analysis of IBD


28 September 2017
Social networking-based discussion group by ERCP doctors


28 September 2017
Incidence of biopsy-verified celiac disease


27 September 2017
Predictors of nonadherence in IBD


27 September 2017
Hep C treatment in the era of direct-acting anti-viral agents


27 September 2017
Function of trypsin-3 in IBS


26 September 2017
Chronic pancreatitis and pancreatic cancer risk


26 September 2017
Factors associated with the risk of metachronous gastric neoplasm


26 September 2017
Treatment of hyperactive delirium in advanced cancer


25 September 2017
Lenalidomide for advanced liver cancer


25 September 2017
Silibinin nanoparticles inhibit HCV infection

GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us